Back
SPDR S&P® North American Natural Res ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
39
NANR
SPDR S&P® North American Natural Res ETF
Last Price:
55.50
Seasonality Move:
-0.1%
Buy
94
LBPH
Longboard Pharmaceuticals
Last Price:
31.81
Seasonality Move:
0.54%
Sell
39
SPDR S&P® North American Natural Res ETF (NANR)
is a Sell
Is SPDR S&P® North American Natural Res ETF a Buy, Sell or Hold?
- The current SPDR S&P® North American Natural Res ETF [NANR] share price is $55.39. The Score for NANR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NANR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
94
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $31.91. The Score for LBPH is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NANR Stock Price Chart
What is SPDR S&P® North American Natural Res ETF's stock price today?
-
The SPDR S&P® North American Natural Res ETF share price today is $55.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NANR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $31.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
NANR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 54.17 | Buy |
Chaikin Money Flow: | 5314 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.61 - 55.73) | Buy |
Bollinger Bands (100): | (50.88 - 57.06) | Buy |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.64 | Buy |
Relative Strength Index (14 RSI): | 83.82 | Buy |
Chaikin Money Flow: | -14813 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.72 - 25.2) | Buy |
Bollinger Bands (100): | (17.96 - 22.88) | Buy |
NANR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.71 | Buy |
20-day SMA: | 54.3 | Buy |
50-day SMA: | 55.79 | Sell |
200-day SMA: | 52.25 | Buy |
8-day EMA: | 54.64 | Buy |
20-day EMA: | 54.71 | Buy |
50-day EMA: | 54.95 | Buy |
200-day EMA: | 53.28 | Buy |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.62 | Buy |
20-day SMA: | 21.6 | Buy |
50-day SMA: | 20.76 | Buy |
200-day SMA: | 15.19 | Buy |
8-day EMA: | 26.93 | Buy |
20-day EMA: | 23.33 | Buy |
50-day EMA: | 21.23 | Buy |
200-day EMA: | 16.56 | Buy |
SPDR S&P® North American Natural Res ETF Earnings Growth & NANR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.56 per share, and a decrease next year of $0.55 per share.
SPDR S&P® North American Natural Res ETF Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |